Progestogen-Mediated Neuroprotection in Central Nervous System Disorders

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Neurosteroids, including progesterone and its analogs (progestogens), are synthesized endogenously and possess neurotrophic, neuroprotective, and anti-inflammatory properties.
• These compounds modulate glial cells and promote myelin repair, offering potential therapeutic avenues for neurological conditions.
• Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, ALS, and MS are characterized by neuronal loss and glial dysfunction.

Purpose of the Study:

• To review the multifaceted actions of progesterone and progestogens in experimental models of neurodegenerative diseases.
• To examine alterations in progestogen levels during pathological conditions and their underlying neuroprotective mechanisms.
• To discuss the potential of progestogens as neuroprotective and regenerative agents, including their role in menopausal hormone replacement therapy.

Main Methods:

• Review of experimental models, epidemiological studies, and clinical trials concerning progestogen effects in neurodegenerative disorders.
• Evaluation of progestogen level modifications in pathological states.
• Analysis of intracellular mechanisms and glial interactions involved in progestogen-mediated neuroprotection.

Main Results:

• Progestogens demonstrate significant neurotrophic, neuroprotective, antioxidant, anti-inflammatory, and remyelinating effects in various preclinical models.
• Pathological conditions associated with neurodegenerative diseases can alter endogenous progestogen levels.
• Intracellular signaling pathways and glial cell modulation are key mechanisms underlying the neuroprotective actions of progestogens.

Conclusions:

• Progesterone and progestogens exhibit considerable potential as neuroprotective and regenerative agents for chronic neurodegenerative diseases.
• Understanding progestogen alterations and mechanisms is crucial for developing effective therapeutic strategies.
• Further investigation into progestogen therapy, including hormone replacement, may offer novel treatments for debilitating neurological conditions.